How peptide technology has improved costs and outcomes in patients with heart failure.

about

How peptide technology has improved costs and outcomes in patients with heart failure.

Item

http://www.wikidata.org/entity/Q38830022

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

How peptide technology has improved costs and outcomes in patients with heart failure.

@en

type

Item

label

How peptide technology has improved costs and outcomes in patients with heart failure.

@en

prefLabel

How peptide technology has improved costs and outcomes in patients with heart failure.

@en

P1476

How peptide technology has improved costs and outcomes in patients with heart failure.

@en

P2093

Ioli Arista

http://www.w3.org/2001/XMLSchema#string

John Kyriopoulos

http://www.w3.org/2001/XMLSchema#string

Kostas Athanasakis

http://www.w3.org/2001/XMLSchema#string

Nadia Boubouchairopoulou

http://www.w3.org/2001/XMLSchema#string

Thanos Balasopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure

The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Natriuretic Peptide testing in primary care

Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.

Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Plasma brain natriuretic peptide concentration: impact of age and gender.

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications

Clinical epidemiology of heart failure.

P304

371-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14737167.2016.1187066

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27160541

http://www.w3.org/2001/XMLSchema#string